Global Organoid Models Market Outlook and Growth Opportunities 2025

Summary

According to APO Research, the global Organoid Models market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Organoid Models is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Organoid Models is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Organoid Models market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Organoid Models is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Organoid Models market include Thermo Fisher Scientific, Merck, Lonza, Ketu Medicine, STEMCELL Technologies, R&D Systems, Prellis Biologics, Corning and Cellesce, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Organoid Models, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Organoid Models, also provides the sales of main regions and countries. Of the upcoming market potential for Organoid Models, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Organoid Models sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Organoid Models market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Organoid Models sales, projected growth trends, production technology, application and end-user industry.

Organoid Models Segment by Company

Thermo Fisher Scientific
Merck
Lonza
Ketu Medicine
STEMCELL Technologies
R&D Systems
Prellis Biologics
Corning
Cellesce
AMSBIO
Organoid Models Segment by Type

Adult Stem Cells (ASCs)
Pluripotent Stem Cells (iPSCs)
Organoid Models Segment by Application

Pharmaceutical
Research Institutes
Precision Medicine
Organoid Models Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Organoid Models status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Organoid Models market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Organoid Models significant trends, drivers, influence factors in global and regions.
6. To analyze Organoid Models competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organoid Models market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organoid Models and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organoid Models.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Organoid Models market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Organoid Models industry.
Chapter 3: Detailed analysis of Organoid Models manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Organoid Models in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Organoid Models in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Organoid Models Sales Value (2020-2031)
1.2.2 Global Organoid Models Sales Volume (2020-2031)
1.2.3 Global Organoid Models Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Organoid Models Market Dynamics
2.1 Organoid Models Industry Trends
2.2 Organoid Models Industry Drivers
2.3 Organoid Models Industry Opportunities and Challenges
2.4 Organoid Models Industry Restraints
3 Organoid Models Market by Company
3.1 Global Organoid Models Company Revenue Ranking in 2024
3.2 Global Organoid Models Revenue by Company (2020-2025)
3.3 Global Organoid Models Sales Volume by Company (2020-2025)
3.4 Global Organoid Models Average Price by Company (2020-2025)
3.5 Global Organoid Models Company Ranking (2023-2025)
3.6 Global Organoid Models Company Manufacturing Base and Headquarters
3.7 Global Organoid Models Company Product Type and Application
3.8 Global Organoid Models Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Organoid Models Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Organoid Models Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Organoid Models Market by Type
4.1 Organoid Models Type Introduction
4.1.1 Adult Stem Cells (ASCs)
4.1.2 Pluripotent Stem Cells (iPSCs)
4.2 Global Organoid Models Sales Volume by Type
4.2.1 Global Organoid Models Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Organoid Models Sales Volume by Type (2020-2031)
4.2.3 Global Organoid Models Sales Volume Share by Type (2020-2031)
4.3 Global Organoid Models Sales Value by Type
4.3.1 Global Organoid Models Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Organoid Models Sales Value by Type (2020-2031)
4.3.3 Global Organoid Models Sales Value Share by Type (2020-2031)
5 Organoid Models Market by Application
5.1 Organoid Models Application Introduction
5.1.1 Pharmaceutical
5.1.2 Research Institutes
5.1.3 Precision Medicine
5.2 Global Organoid Models Sales Volume by Application
5.2.1 Global Organoid Models Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Organoid Models Sales Volume by Application (2020-2031)
5.2.3 Global Organoid Models Sales Volume Share by Application (2020-2031)
5.3 Global Organoid Models Sales Value by Application
5.3.1 Global Organoid Models Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Organoid Models Sales Value by Application (2020-2031)
5.3.3 Global Organoid Models Sales Value Share by Application (2020-2031)
6 Organoid Models Regional Sales and Value Analysis
6.1 Global Organoid Models Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Organoid Models Sales by Region (2020-2031)
6.2.1 Global Organoid Models Sales by Region: 2020-2025
6.2.2 Global Organoid Models Sales by Region (2026-2031)
6.3 Global Organoid Models Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Organoid Models Sales Value by Region (2020-2031)
6.4.1 Global Organoid Models Sales Value by Region: 2020-2025
6.4.2 Global Organoid Models Sales Value by Region (2026-2031)
6.5 Global Organoid Models Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Organoid Models Sales Value (2020-2031)
6.6.2 North America Organoid Models Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Organoid Models Sales Value (2020-2031)
6.7.2 Europe Organoid Models Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Organoid Models Sales Value (2020-2031)
6.8.2 Asia-Pacific Organoid Models Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Organoid Models Sales Value (2020-2031)
6.9.2 South America Organoid Models Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Organoid Models Sales Value (2020-2031)
6.10.2 Middle East & Africa Organoid Models Sales Value Share by Country, 2024 VS 2031
7 Organoid Models Country-level Sales and Value Analysis
7.1 Global Organoid Models Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Organoid Models Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Organoid Models Sales by Country (2020-2031)
7.3.1 Global Organoid Models Sales by Country (2020-2025)
7.3.2 Global Organoid Models Sales by Country (2026-2031)
7.4 Global Organoid Models Sales Value by Country (2020-2031)
7.4.1 Global Organoid Models Sales Value by Country (2020-2025)
7.4.2 Global Organoid Models Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Organoid Models Sales Value Growth Rate (2020-2031)
7.5.2 USA Organoid Models Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Organoid Models Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Organoid Models Sales Value Growth Rate (2020-2031)
7.6.2 Canada Organoid Models Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Organoid Models Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Organoid Models Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Organoid Models Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Organoid Models Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Organoid Models Sales Value Growth Rate (2020-2031)
7.8.2 Germany Organoid Models Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Organoid Models Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Organoid Models Sales Value Growth Rate (2020-2031)
7.9.2 France Organoid Models Sales Value Share by Type, 2024 VS 2031
7.9.3 France Organoid Models Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Organoid Models Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Organoid Models Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Organoid Models Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Organoid Models Sales Value Growth Rate (2020-2031)
7.11.2 Italy Organoid Models Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Organoid Models Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Organoid Models Sales Value Growth Rate (2020-2031)
7.12.2 Spain Organoid Models Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Organoid Models Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Organoid Models Sales Value Growth Rate (2020-2031)
7.13.2 Russia Organoid Models Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Organoid Models Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Organoid Models Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Organoid Models Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Organoid Models Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Organoid Models Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Organoid Models Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Organoid Models Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Organoid Models Sales Value Growth Rate (2020-2031)
7.16.2 China Organoid Models Sales Value Share by Type, 2024 VS 2031
7.16.3 China Organoid Models Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Organoid Models Sales Value Growth Rate (2020-2031)
7.17.2 Japan Organoid Models Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Organoid Models Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Organoid Models Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Organoid Models Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Organoid Models Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Organoid Models Sales Value Growth Rate (2020-2031)
7.19.2 India Organoid Models Sales Value Share by Type, 2024 VS 2031
7.19.3 India Organoid Models Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Organoid Models Sales Value Growth Rate (2020-2031)
7.20.2 Australia Organoid Models Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Organoid Models Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Organoid Models Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Organoid Models Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Organoid Models Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Organoid Models Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Organoid Models Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Organoid Models Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Organoid Models Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Organoid Models Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Organoid Models Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Organoid Models Sales Value Growth Rate (2020-2031)
7.24.2 Chile Organoid Models Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Organoid Models Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Organoid Models Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Organoid Models Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Organoid Models Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Organoid Models Sales Value Growth Rate (2020-2031)
7.26.2 Peru Organoid Models Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Organoid Models Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Organoid Models Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Organoid Models Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Organoid Models Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Organoid Models Sales Value Growth Rate (2020-2031)
7.28.2 Israel Organoid Models Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Organoid Models Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Organoid Models Sales Value Growth Rate (2020-2031)
7.29.2 UAE Organoid Models Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Organoid Models Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Organoid Models Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Organoid Models Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Organoid Models Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Organoid Models Sales Value Growth Rate (2020-2031)
7.31.2 Iran Organoid Models Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Organoid Models Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Organoid Models Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Organoid Models Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Organoid Models Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Thermo Fisher Scientific
8.1.1 Thermo Fisher Scientific Comapny Information
8.1.2 Thermo Fisher Scientific Business Overview
8.1.3 Thermo Fisher Scientific Organoid Models Sales, Value and Gross Margin (2020-2025)
8.1.4 Thermo Fisher Scientific Organoid Models Product Portfolio
8.1.5 Thermo Fisher Scientific Recent Developments
8.2 Merck
8.2.1 Merck Comapny Information
8.2.2 Merck Business Overview
8.2.3 Merck Organoid Models Sales, Value and Gross Margin (2020-2025)
8.2.4 Merck Organoid Models Product Portfolio
8.2.5 Merck Recent Developments
8.3 Lonza
8.3.1 Lonza Comapny Information
8.3.2 Lonza Business Overview
8.3.3 Lonza Organoid Models Sales, Value and Gross Margin (2020-2025)
8.3.4 Lonza Organoid Models Product Portfolio
8.3.5 Lonza Recent Developments
8.4 Ketu Medicine
8.4.1 Ketu Medicine Comapny Information
8.4.2 Ketu Medicine Business Overview
8.4.3 Ketu Medicine Organoid Models Sales, Value and Gross Margin (2020-2025)
8.4.4 Ketu Medicine Organoid Models Product Portfolio
8.4.5 Ketu Medicine Recent Developments
8.5 STEMCELL Technologies
8.5.1 STEMCELL Technologies Comapny Information
8.5.2 STEMCELL Technologies Business Overview
8.5.3 STEMCELL Technologies Organoid Models Sales, Value and Gross Margin (2020-2025)
8.5.4 STEMCELL Technologies Organoid Models Product Portfolio
8.5.5 STEMCELL Technologies Recent Developments
8.6 R&D Systems
8.6.1 R&D Systems Comapny Information
8.6.2 R&D Systems Business Overview
8.6.3 R&D Systems Organoid Models Sales, Value and Gross Margin (2020-2025)
8.6.4 R&D Systems Organoid Models Product Portfolio
8.6.5 R&D Systems Recent Developments
8.7 Prellis Biologics
8.7.1 Prellis Biologics Comapny Information
8.7.2 Prellis Biologics Business Overview
8.7.3 Prellis Biologics Organoid Models Sales, Value and Gross Margin (2020-2025)
8.7.4 Prellis Biologics Organoid Models Product Portfolio
8.7.5 Prellis Biologics Recent Developments
8.8 Corning
8.8.1 Corning Comapny Information
8.8.2 Corning Business Overview
8.8.3 Corning Organoid Models Sales, Value and Gross Margin (2020-2025)
8.8.4 Corning Organoid Models Product Portfolio
8.8.5 Corning Recent Developments
8.9 Cellesce
8.9.1 Cellesce Comapny Information
8.9.2 Cellesce Business Overview
8.9.3 Cellesce Organoid Models Sales, Value and Gross Margin (2020-2025)
8.9.4 Cellesce Organoid Models Product Portfolio
8.9.5 Cellesce Recent Developments
8.10 AMSBIO
8.10.1 AMSBIO Comapny Information
8.10.2 AMSBIO Business Overview
8.10.3 AMSBIO Organoid Models Sales, Value and Gross Margin (2020-2025)
8.10.4 AMSBIO Organoid Models Product Portfolio
8.10.5 AMSBIO Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Organoid Models Value Chain Analysis
9.1.1 Organoid Models Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Organoid Models Sales Mode & Process
9.2 Organoid Models Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Organoid Models Distributors
9.2.3 Organoid Models Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings